维普中文期刊产品整合服务
123篇 您的检索式:作者名="Butler GS"
    题名 作者 年代 出处 被引量
1The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy显示文摘Niehaus A Merrick GS Butler WM 2006Int J Radiat Oncol Biol Phys2006,64,1:1
2Syndrome of periodic fe- ver,pharyngitis, and aphthous stomatitis 显示文摘Marshall GS Edwards KM Butler J 1987J Pediatr1987,110,1:1
3Seed fixity in the prostate/periprostatic region following brachytherapy 显示文摘Merriek GS Butler WM Dorsey AT 2000hat Radiat Oncol Biol Phys2000,46,1:1
4Brachytherapy-related dysuria显示文摘Merrick GS Butler WM Wallner KE 2005BJU Int2005,95,4:1
5Matrix metal-loproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1显示文摘Mcquibban GA Butler GS Gong JH 0,,06:1
6An orally administered growth factor extract derived form bovine when suppresses breath ethane in colitic rats显示文摘Porter SN Howarth GS Butler RN 1998Scand J Gastroenterol1998,33,8:1
7Dosimetry of extracapsular anulus following permanet prostate brachytherapy 显示文摘Merriek GS Butler WM Wallner KE 2007Am J Clin Oncol2007,30,3:1
8Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the drug-resistant Streptococcus pneumoniae therapeutic working group 显示文摘Dowell SF Butler JC Giebink GS 1999Pediatr Infect Dis J1999,18,:1
9The influence of isotope and prostate volume on urinary mobidity after prostate brachytherapy 显示文摘Niehaus A Merrick GS Butler WM 2005Int J Radiat Oncol Biol Phys2005,64,1:1
10Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2- independent pathway显示文摘Morrison CJ Butler GS Bigg HF 2001J Biol Chem2001,276,47:1
11Long-term outcome for clin- ically localized prostate cancer treated with permanent interstitial brachytherapy显示文摘Taira AV Merrick GS Butler WM 2011Int J Radiat Oncol Biol Phys2011,79,5:1
12Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland显示文摘Merrick GS W allner KE Butler WM 2003J Urol2003,169,:1
13Cellular activation of MMP-2 (Gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway显示文摘Morrison CJ Butler GS Bigg HF 2001Biol Chem2001,276,47:1
14Rectal function following Prostate brachytherapy显示文摘Merrick GS Butler WM Dorsey AT 2000Int J Radiat Oncol Biol Phys2000,48,3:1
15Modified uniform seed loading for prostate brachytherapy:rationale,design and evaluation显示文摘MerriCk GS and Butler WM 2000Tech Urol2000,6,:1
16Detailed urethral dosi-metry in the evaluation of prostate brachytherapy-related urinarymorbidity 显示文摘Allen Z Merrick GS Butler WM 2005Int J Radiat Oncol Biol Phys2005,62,4:1
17Influ ence of body mass index on biochemical outcome after permanent prostate brachytherapy显示文摘MERRICK GS BUTLER WM WALLNER KE 2005Urology2005,65,1:1
18Collagen binding properties of the MT1-MMP hemopexin C domain: The ectodomain of the 44-kDa autocatalytic fragment of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage显示文摘Tam EM Wu YI Butler GS 2002J Biol Chem2002,277,39:1
19Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland 显示文摘Merrick GS Butler WM Galbreath RW 2002Int J Radiat Oncol Bioi Phys2002,52,3:1
20Identification of candidate an- giogenic inhibitors processed by matrix metalloproteinase 2 ( MMP-2 ) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotro- phin) and VEGF/Connective tissue growth factor angiogenic inhibito- ry complexes by MMP-2 proteolysis 显示文摘Dean RA Butler GS Kourbali Y 2007Mol Cell Biol2007,27,24:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费